2034年全球輸液幫浦電子市場預測－按泵浦類型、應用、最終用戶和地區分類的全球分析

根據 Stratistics MRC 預測，全球輸液幫浦電子市場規模預計將在 2026 年達到 21 億美元，並在預測期內以 9.0% 的複合年成長率成長，到 2034 年達到 43 億美元。

輸液幫浦電子元件是指輸液幫浦和攜帶式輸液裝置中用於調節和監測藥物控制輸注的電子機制。這些系統通常由處理器、感測元件、電源控制單元和通訊介面組成，它們協同工作以確保輸注的準確性和運作安全性。對先進泵浦電子元件的需求不斷成長，主要源於醫療保健需求的增加，尤其是對糖尿病、癌症和慢性疼痛等疾病長期治療的需求。現代設備還支援無線通訊和與數位健康平台的整合，從而實現即時監測和更完善的患者管理。小型化電子元件、節能電池和智慧安全機制的不斷進步，推動了可靠且方便用戶使用的輸液泵技術的發展。

根據國際糖尿病聯盟（IDF）的數據，預計到 2030 年，全球糖尿病患者人數將達到 6.43 億，這將直接推動胰島素幫浦和智慧注射器等電子藥物輸送系統的發展。

慢性病盛行率增加

糖尿病、癌症、心血管疾病和神經系統疾病等慢性病患者人數的不斷增加，顯著推動了對輸液幫浦電子設備的需求。長期病患通常需要精準且持續的藥物輸注，而現代輸液幫浦能夠有效率地滿足這項需求。這些設備內部的電子元件能夠調節劑量精度、監測安全參數並維持穩定運作。隨著全球人口老化和文明病的日益增多，醫療保健系統對自動化藥物輸注技術的應用也日益廣泛。

高昂的研發和製造成本

藥物輸送泵電子市場的主要限制因素之一是複雜電子系統的設計和製造成本高。這些幫浦依靠高精度感測器、先進的微控制器和可靠的監控電路來確保藥物安全、精準地輸送。實施這些技術需要大量的研發、專門的製造流程和嚴格的測試程序，增加了整體製造成本。此外，滿足嚴格的法規和安全要求也會給製造商帶來額外的財務負擔。對於小規模的公司而言，投資如此昂貴的研發流程可能十分困難。

穿戴式藥物輸送裝置的擴展

穿戴式藥物輸送技術的日益普及，為藥物輸送泵電子元件市場創造了強勁的成長潛力。穿戴式輸注系統使患者能夠持續接受藥物治療，而無需限制其行動或日常活動。這些設備依靠先進的電子元件來控制劑量精度、監測性能並保持高效的電力消耗。人們對便捷治療方法的日益關注，尤其是在糖尿病和其他慢性疾病的管理方面，正在推動穿戴式解決方案的普及。更小的電路、更先進的感測器技術和更高的電池效率進一步促進了產品創新。隨著個人化行動醫療的日益普及，穿戴式藥物輸送泵電子元件市場預計將快速成長。

產品召回和安全問題增多

設備召回和安全問題日益增多，對輸液幫浦電子市場構成重大風險。這些幫浦依賴精密的電子元件來精確輸送藥物。軟體、感測器或電子控制系統的故障可能導致劑量錯誤，危及患者健康。一旦出現此類問題，製造商可能面臨強制召回、法律訴訟和聲譽損害。監管機構也正在針對安全問題進行嚴格評估。這些措施可能會降低醫療專業人員和使用者的信心。因此，反覆的召回和安全問題可能會對輸液幫浦先進電子元件的普及和發展產生負面影響。

新冠疫情的影響：

新冠疫情為輸液幫浦電子市場帶來了挑戰和成長機會。初期，全球供應鏈中斷、工廠關閉以及半導體元件短缺影響了輸液幫浦及相關電子系統的生產。儘管面臨這些挑戰，醫院對用於治療需要持續輸液和液體療法的緊急醫療設備的需求卻激增。在這場公共衛生危機中，輸液幫浦在加護病房發揮了至關重要的作用。此外，疫情期間對遠端患者監護和居家醫療服務的日益重視也推動了輸液幫浦採用技術先進、數位化連接的電子系統。

在預測期內，輸液幫浦細分市場預計將佔據最大的市場佔有率。

由於輸液幫浦在醫療機構和居家照護中廣泛用於藥物和液體的管理和輸注，預計在預測期內，輸液幫浦細分市場將佔據最大的市場佔有率。這些設備依賴先進的電子元件來確保精準的藥物輸送、運作監測和病人安全。輸液幫浦廣泛應用於重症監護、外科手術、腫瘤治療和長期疾病管理等領域。它們能夠提供持續或定時的藥物輸送，使其成為醫療專業人員的寶貴設備。隨著醫院擴大採用自動化藥物輸送技術來提高治療效率，輸液幫浦將繼續保持其市場主導地位。

在預測期內，糖尿病管理細分市場預計將呈現最高的複合年成長率。

在預測期內，糖尿病管理領域預計將呈現最高的成長率，這主要歸因於全球糖尿病患者人數的不斷增加。電子輸注幫浦被廣泛用於確保胰島素的精準輸注，並幫助維持血糖值的穩定性。這些系統減少了頻繁注射的需要，使患者的長期疾病管理更加便捷。人們對自動化胰島素輸注設備、穿戴式治療方案和數位化互聯監測技術的興趣日益濃厚，推動了這些技術的應用。科技的持續進步和對高效糖尿病護理解決方案的需求，極大地促進了該領域的快速發展。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其高度發達的醫療保健體系、先進醫療技術的廣泛應用以及眾多大型醫療設備公司的存在。該地區的醫療服務提供者越來越依賴電子輸液幫浦來確保藥物的精準給藥並改善患者照護。慢性病患者數量的不斷成長也推動了對先進輸液技術的強勁需求。此外，有利的監管標準、持續的技術進步以及對醫療創新的巨額投資，都鞏固了該地區的領先地位，並使其在全球市場中保持著較高的佔有率。

複合年成長率最高的地區：

在預測期內，隨著醫療保健體系的持續發展和現代醫療技術的日益普及，亞太地區預計將呈現最高的複合年成長率。人口成長、對先進治療方法的認知度不斷提高以及慢性病負擔日益加重，都在推動對自動化藥物輸送解決方案的需求。許多國家的政府正致力於加強醫療基礎建設，並推廣創新醫療設備的使用。醫院擴建、醫療服務可近性的提升以及人們對居家照護方案日益成長的興趣，都進一步促進了市場成長。預計這些趨勢將顯著加速亞太地區泵類電子產品的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

• 企業概況
  • 對其他市場參與者（最多 3 家公司）進行全面分析
  • 對主要企業進行SWOT分析（最多3家公司）
• 區域細分
  • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
• 競爭性標竿分析
  • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

• 市場概覽及主要亮點
• 促進因素、挑戰與機遇
• 競爭格局概述
• 戰略洞察與建議

第2章：研究框架

• 研究目標和範圍
• 相關人員分析
• 研究假設和限制
• 調查方法

第3章 市場動態與趨勢分析

• 市場定義與結構
• 主要市場促進因素
• 市場限制與挑戰
• 投資成長機會和重點領域
• 產業威脅與風險評估
• 技術與創新展望
• 新興市場/高成長市場
• 監管和政策環境
• 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

• 波特五力分析
  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭
• 主要企業市佔率分析
• 產品基準評效和效能比較

第5章：全球輸液幫浦電子市場：依幫浦類型分類

• 注射式幫浦
• 點滴幫浦
• 嵌入式泵浦
• 胰島素幫浦
• 彈性體泵

第6章：全球藥物輸送幫浦電子市場：依應用領域分類

• 糖尿病管理
• 腫瘤學
• 疼痛管理
• 心血管疾病
• 神經病學
• 胃腸病學
• 感染疾病

第7章 全球藥物輸送幫浦電子市場：依最終用戶分類

• 醫院和診所
• 門診手術中心
• 居家醫療環境
• 專業醫療中心

第8章 全球輸液幫浦電子市場：依地區分類

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 比利時
  • 瑞典
  • 瑞士
  • 波蘭
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 泰國
  • 馬來西亞
  • 新加坡
  • 越南
  • 其他亞太國家
• 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 智利
  • 秘魯
  • 其他南美國家
• 世界其他地區（RoW）
  • 中東
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 埃及
    • 摩洛哥
    • 其他非洲國家

第9章 戰略市場資訊

• 工業價值網路和供應鏈評估
• 空白區域和機會地圖
• 產品演進與市場生命週期分析
• 通路、經銷商和打入市場策略的評估

第10章：產業趨勢與策略舉措

• 併購
• 夥伴關係、聯盟和合資企業
• 新產品發布和認證
• 擴大生產能力和投資
• 其他策略舉措

第11章：公司簡介

• Medtronic plc
• Becton, Dickinson and Company
• Baxter International Inc.
• B. Braun Melsungen AG
• Tandem Diabetes Care, Inc.
• Ypsomed AG
• Insulet Corporation
• Novo Nordisk
• Eli Lilly and Company
• West Pharmaceutical Services
• Gerresheimer
• Fresenius Kabi AG
• Debiotech SA
• Flowonix Medical, Inc.
• AstraZeneca plc
• Smiths Medical
• Stevanato Group
• Epsilon Electronics

According to Stratistics MRC, the Global Drug Delivery Pump Electronics Market is accounted for $2.1 billion in 2026 and is expected to reach $4.3 billion by 2034 growing at a CAGR of 9.0% during the forecast period. Drug delivery pump electronics refer to the electronic mechanisms responsible for regulating and supervising the controlled dispensing of medications in infusion pumps and portable drug delivery devices. These systems typically consist of processors, sensing elements, power control units, and communication interfaces that work together to maintain dosing precision and operational safety. Rising healthcare needs, especially for long-term treatment of conditions such as diabetes, cancer, and chronic pain, is increasing the demand for advanced pump electronics. Modern devices also support wireless communication and integration with digital health platforms, enabling real-time monitoring and improved patient management. Ongoing advancements in compact electronic components, energy-efficient batteries, and intelligent safety mechanisms are supporting the development of highly reliable and user-friendly drug delivery pump technologies.

According to the International Diabetes Federation (IDF), the global diabetes prevalence is expected to rise to 643 million by 2030, which directly supports the growth of electronic drug delivery systems like insulin pumps and smart injectors.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The growing number of people affected by chronic health conditions including diabetes, cancer, cardiovascular diseases, and neurological disorders is significantly boosting the demand for drug delivery pump electronics. Individuals with long-term illnesses often require precise and continuous medication delivery, which modern infusion pumps can provide efficiently. The electronic components within these devices regulate dosage accuracy, monitor safety parameters, and maintain consistent operation. With aging populations and increasing lifestyle-related health challenges worldwide, healthcare systems are adopting automated drug delivery technologies more frequently.

Restraint:

High development and manufacturing costs

One significant limitation in the drug delivery pump electronics market is the substantial cost involved in designing and producing sophisticated electronic systems. These pumps rely on highly precise sensors, advanced microcontrollers, and dependable monitoring circuits to ensure safe and accurate medication delivery. Implementing these technologies requires extensive research, specialized manufacturing processes, and rigorous testing procedures, which increase overall production costs. Additionally, meeting strict regulatory and safety requirements adds further financial pressure on manufacturers. Smaller companies may find it difficult to invest in such expensive development processes.

Opportunity:

Expansion of wearable drug delivery devices

The growing popularity of wearable drug delivery technologies offers strong growth potential for the drug delivery pump electronics market. Wearable infusion systems enable patients to receive medications continuously without restricting movement or everyday routines. These devices depend on advanced electronic components to control dosage precision, monitor performance, and maintain efficient power consumption. Increasing interest in convenient treatment options, especially for managing diabetes and other chronic conditions, is encouraging wider adoption of wearable solutions. Improvements in compact circuitry, sensor technology, and battery efficiency are further supporting product innovation. As personalized and mobile healthcare becomes more common, wearable drug delivery pump electronics are likely to expand rapidly.

Threat:

Increasing product recalls and safety incidents

Rising cases of device recalls and safety-related issues pose a major risk to the drug delivery pump electronics market. These pumps depend on sophisticated electronic components to administer medications with high precision. Failures in software, sensors, or electronic control systems may cause incorrect dosage delivery, potentially endangering patient health. When such problems occur, manufacturers may face mandatory product recalls, legal consequences, and reputational damage. Regulatory authorities also conduct strict evaluations following safety concerns. These developments can decrease confidence among healthcare providers and users. As a result, repeated recalls and safety problems may negatively influence the adoption and growth of advanced pump electronics.

Covid-19 Impact:

The COVID-19 pandemic created both challenges and growth opportunities for the drug delivery pump electronics market. Initially, global supply chain interruptions, factory closures, and shortages of semiconductor components affected the manufacturing of infusion pumps and related electronic systems. Despite these challenges, hospitals experienced a surge in demand for critical care devices to treat patients requiring constant medication delivery and fluid therapy. Infusion pumps played an important role in intensive care settings during the health crisis. Moreover, the increased focus on remote patient monitoring and home healthcare services during the pandemic encouraged the adoption of technologically advanced and digitally connected drug delivery pump electronic systems.

The infusion pumps segment is expected to be the largest during the forecast period

The infusion pumps segment is expected to account for the largest market share during the forecast period because of their extensive application in medical facilities and home-based care for controlled drug and fluid administration. These devices depend on sophisticated electronic components to ensure precise medication delivery, operational monitoring, and patient safety. Infusion pumps are widely utilized in critical care environments, surgical treatments, oncology therapy, and long-term disease management. Their capability to provide continuous or scheduled medication dosing makes them highly valuable for healthcare professionals. As hospitals increasingly adopt automated drug administration technologies to enhance treatment efficiency, infusion pumps continue to maintain a leading position in the market.

The diabetes management segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diabetes management segment is predicted to witness the highest growth rate, mainly because of the increasing number of individuals affected by diabetes worldwide. Electronic drug delivery pumps are widely used to deliver accurate insulin doses and assist in maintaining stable glucose levels. These systems reduce the need for frequent injections and make long-term disease management more convenient for patients. Growing interest in automated insulin delivery devices, wearable treatment solutions, and digitally connected monitoring technologies is encouraging wider adoption. Ongoing technological advancements and the need for efficient diabetes care solutions are significantly supporting the rapid expansion of this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its well-developed healthcare systems, widespread use of modern medical technologies, and the presence of major medical device companies. Healthcare institutions across the region increasingly rely on electronic drug delivery pumps to ensure precise medication administration and enhance patient care. The rising number of patients suffering from chronic illnesses also contributes to the strong demand for advanced drug delivery technologies. Furthermore, supportive regulatory standards, ongoing technological advancements, and substantial investments in healthcare innovation strengthen the region's leadership and maintain its significant share in the global market.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR as healthcare systems continue to develop and modern medical technologies gain wider acceptance. Increasing population levels, greater awareness about advanced treatments, and the growing burden of chronic illnesses are driving demand for automated drug delivery solutions. Many governments are focusing on strengthening healthcare infrastructure and encouraging the use of innovative medical equipment. The expansion of hospitals, improved access to healthcare services, and rising interest in home-based treatment options are further supporting market expansion. These developments are expected to significantly accelerate the growth of pump electronics in Asia-Pacific.

Key players in the market

Some of the key players in Drug Delivery Pump Electronics Market include Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Tandem Diabetes Care, Inc., Ypsomed AG, Insulet Corporation, Novo Nordisk, Eli Lilly and Company, West Pharmaceutical Services, Gerresheimer, Fresenius Kabi AG, Debiotech SA, Flowonix Medical, Inc., AstraZeneca plc, Smiths Medical, Stevanato Group and Epsilon Electronics

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In September 2025, Becton Dickinson Korea said that it signed a tripartite strategic memorandum of understanding with BD Global and Celltrion Pharm at the latter's research institute in Songdo, Incheon, for contract manufacturing organization (CMO) cooperation on prefilled syringes (PFS). Through this agreement, the three companies plan to collaborate by connecting and guiding business opportunities for pharmaceutical companies requiring PFS CMO services, leveraging BD's global syringe customer network and Celltrion Pharm's production capabilities.

In June 2025, Baxter International Inc. announced on the signing of an amended and restated five-year credit agreement, increasing its borrowing capacity to $2.2 billion. According to InvestingPro analysis, the company appears undervalued based on its Fair Value metrics. This move amends the existing $2 billion revolving credit facility, and replaces a €200 million credit facility that was terminated concurrently with the new agreement.

Pump Types Covered:

• Syringe Pumps
• Infusion Pumps
• Implantable Pumps
• Insulin Pumps
• Elastomeric Pumps

Applications Covered:

• Diabetes Management
• Oncology
• Pain Management
• Cardiovascular Disorders
• Neurology
• Gastroenterology
• Infectious Diseases

End Users Covered:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Specialty Centers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Drug Delivery Pump Electronics Market, By Pump Type

• 5.1 Syringe Pumps
• 5.2 Infusion Pumps
• 5.3 Implantable Pumps
• 5.4 Insulin Pumps
• 5.5 Elastomeric Pumps

6 Global Drug Delivery Pump Electronics Market, By Application

• 6.1 Diabetes Management
• 6.2 Oncology
• 6.3 Pain Management
• 6.4 Cardiovascular Disorders
• 6.5 Neurology
• 6.6 Gastroenterology
• 6.7 Infectious Diseases

7 Global Drug Delivery Pump Electronics Market, By End User

• 7.1 Hospitals & Clinics
• 7.2 Ambulatory Surgical Centers
• 7.3 Home Care Settings
• 7.4 Specialty Centers

8 Global Drug Delivery Pump Electronics Market, By Geography

• 8.1 North America
  • 8.1.1 United States
  • 8.1.2 Canada
  • 8.1.3 Mexico
• 8.2 Europe
  • 8.2.1 United Kingdom
  • 8.2.2 Germany
  • 8.2.3 France
  • 8.2.4 Italy
  • 8.2.5 Spain
  • 8.2.6 Netherlands
  • 8.2.7 Belgium
  • 8.2.8 Sweden
  • 8.2.9 Switzerland
  • 8.2.10 Poland
  • 8.2.11 Rest of Europe
• 8.3 Asia Pacific
  • 8.3.1 China
  • 8.3.2 Japan
  • 8.3.3 India
  • 8.3.4 South Korea
  • 8.3.5 Australia
  • 8.3.6 Indonesia
  • 8.3.7 Thailand
  • 8.3.8 Malaysia
  • 8.3.9 Singapore
  • 8.3.10 Vietnam
  • 8.3.11 Rest of Asia Pacific
• 8.4 South America
  • 8.4.1 Brazil
  • 8.4.2 Argentina
  • 8.4.3 Colombia
  • 8.4.4 Chile
  • 8.4.5 Peru
  • 8.4.6 Rest of South America
• 8.5 Rest of the World (RoW)
  • 8.5.1 Middle East
    • 8.5.1.1 Saudi Arabia
    • 8.5.1.2 United Arab Emirates
    • 8.5.1.3 Qatar
    • 8.5.1.4 Israel
    • 8.5.1.5 Rest of Middle East
  • 8.5.2 Africa
    • 8.5.2.1 South Africa
    • 8.5.2.2 Egypt
    • 8.5.2.3 Morocco
    • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

• 9.1 Industry Value Network and Supply Chain Assessment
• 9.2 White-Space and Opportunity Mapping
• 9.3 Product Evolution and Market Life Cycle Analysis
• 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

• 10.1 Mergers and Acquisitions
• 10.2 Partnerships, Alliances, and Joint Ventures
• 10.3 New Product Launches and Certifications
• 10.4 Capacity Expansion and Investments
• 10.5 Other Strategic Initiatives

11 Company Profiles

• 11.1 Medtronic plc
• 11.2 Becton, Dickinson and Company
• 11.3 Baxter International Inc.
• 11.4 B. Braun Melsungen AG
• 11.5 Tandem Diabetes Care, Inc.
• 11.6 Ypsomed AG
• 11.7 Insulet Corporation
• 11.8 Novo Nordisk
• 11.9 Eli Lilly and Company
• 11.10 West Pharmaceutical Services
• 11.11 Gerresheimer
• 11.12 Fresenius Kabi AG
• 11.13 Debiotech SA
• 11.14 Flowonix Medical, Inc.
• 11.15 AstraZeneca plc
• 11.16 Smiths Medical
• 11.17 Stevanato Group
• 11.18 Epsilon Electronics

List of Tables

• Table 1 Global Drug Delivery Pump Electronics Market Outlook, By Region (2023-2034) ($MN)
• Table 2 Global Drug Delivery Pump Electronics Market Outlook, By Pump Type (2023-2034) ($MN)
• Table 3 Global Drug Delivery Pump Electronics Market Outlook, By Syringe Pumps (2023-2034) ($MN)
• Table 4 Global Drug Delivery Pump Electronics Market Outlook, By Infusion Pumps (2023-2034) ($MN)
• Table 5 Global Drug Delivery Pump Electronics Market Outlook, By Implantable Pumps (2023-2034) ($MN)
• Table 6 Global Drug Delivery Pump Electronics Market Outlook, By Insulin Pumps (2023-2034) ($MN)
• Table 7 Global Drug Delivery Pump Electronics Market Outlook, By Elastomeric Pumps (2023-2034) ($MN)
• Table 8 Global Drug Delivery Pump Electronics Market Outlook, By Application (2023-2034) ($MN)
• Table 9 Global Drug Delivery Pump Electronics Market Outlook, By Diabetes Management (2023-2034) ($MN)
• Table 10 Global Drug Delivery Pump Electronics Market Outlook, By Oncology (2023-2034) ($MN)
• Table 11 Global Drug Delivery Pump Electronics Market Outlook, By Pain Management (2023-2034) ($MN)
• Table 12 Global Drug Delivery Pump Electronics Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
• Table 13 Global Drug Delivery Pump Electronics Market Outlook, By Neurology (2023-2034) ($MN)
• Table 14 Global Drug Delivery Pump Electronics Market Outlook, By Gastroenterology (2023-2034) ($MN)
• Table 15 Global Drug Delivery Pump Electronics Market Outlook, By Infectious Diseases (2023-2034) ($MN)
• Table 16 Global Drug Delivery Pump Electronics Market Outlook, By End User (2023-2034) ($MN)
• Table 17 Global Drug Delivery Pump Electronics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
• Table 18 Global Drug Delivery Pump Electronics Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
• Table 19 Global Drug Delivery Pump Electronics Market Outlook, By Home Care Settings (2023-2034) ($MN)
• Table 20 Global Drug Delivery Pump Electronics Market Outlook, By Specialty Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.